ZeOmega Launches HealthFeed SMS Texting for Enhanced Member Engagement

Cresset Successfully Achieves SOC 2 Compliance

AKASA Unveils AKASA Medical CodingTM for Enhanced Revenue Cycle Management with Generative AI

TP-ACO Selects YouScript for Personalized Medication Management Initiative

Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology

Instem, a leading provider of IT solutions and services to the global life sciences market, has partnered with Proscia®, a global leader in AI-enhanced pathology solutions for precision medicine.

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

ProPharma Honored with 2024 CRO Leadership Award

ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.

Huateng Pharma to Exhibit at CPHI China 2024

New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease

A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.

Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics

Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.

Onyx Scientific Aims for European Growth with New BD Hire

Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer

Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).

Integrated DNA Technologies Announces New Primers and Probe Set to Identify H5N1 Avian Influenza

Integrated DNA Technologies today launched the Avian Influenza Type A (H5) Primers and Probe Set to enable researchers to identify, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across bird, environmental, dairy cow, and poultry farm samples.

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.

CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program

Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials